Literature DB >> 30484553

Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment.

Juncal Ruiz-Rivero1, Celia Horcajada-Reales1, Juan C Tardío2, Jesús Manuel Borbujo-Martínez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30484553      PMCID： PMC6256228          DOI： 10.1590/abd1806-4841.20187968

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


× No keyword cloud information.
  5 in total

1.  Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report.

Authors:  Younghoon Kwon; Mardi Gomberg-Maitland; Marc Pritzker; Thenappan Thenappan
Journal:  Chest       Date:  2016-04       Impact factor: 9.410

2.  Trastuzumab emtansine for HER2-positive advanced breast cancer.

Authors:  Sunil Verma; David Miles; Luca Gianni; Ian E Krop; Manfred Welslau; José Baselga; Mark Pegram; Do-Youn Oh; Véronique Diéras; Ellie Guardino; Liang Fang; Michael W Lu; Steven Olsen; Kim Blackwell
Journal:  N Engl J Med       Date:  2012-10-01       Impact factor: 91.245

3.  Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series.

Authors:  Vincent Sibaud; Rachel E Niec; Katja Schindler; Klaus J Busam; Henri Roché; Shanu Modi; Jean Pierre Delord; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2014-06-15       Impact factor: 4.872

Review 4.  Breast Cancer: Epidemiology and Etiology.

Authors:  ZiQi Tao; Aimin Shi; Cuntao Lu; Tao Song; Zhengguo Zhang; Jing Zhao
Journal:  Cell Biochem Biophys       Date:  2015-06       Impact factor: 2.194

Review 5.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance.

Authors:  Jaafar Makki
Journal:  Clin Med Insights Pathol       Date:  2015-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.